December 17, 2010

Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

November 7, 2010

Eli Lilly's acquisition of a leader in molecular imaging development could boost its Alzheimer's disease...

November 4, 2010

The Food and Drug Administration has approved a new usage for a drug used to...

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

October 17, 2010

A popular beauty treatment has won approval as a medical treatment as well....

October 17, 2010

A company that develops drugs for pain is hoping to get approval of one of...

October 3, 2010

Privately owned drug-development company ProteoTech will work with a Chinese company to develop a drug...

September 21, 2010

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

August 31, 2010

Pfizer announced Wednesday that it will acquire a privately held drug discovery and clinical development...

August 26, 2010

Topical BioMedics on Thursday announced that its Topricin pain relief and healing cream has been...

August 16, 2010

Lackluster results have prompted Eli Lilly to stop two late-stage clinical trials of a drug...

August 16, 2010

US WorldMeds has acquired Solstice Neurosciences for $35.7 million, US WorldMeds said....

August 2, 2010

Reed's, the maker of a line of sodas popular in natural food stores, on Tuesday...

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....

August 1, 2010

The Food and Drug Administration has approved a generic injected drug made by Sagent Pharmaceuticals...

July 19, 2010

Drug maker Pfizer is suspending some clinical studies of a biotech drug for treating pain...

July 19, 2010

More than 300 medications for treating mental disorders are in development, according to a new...

July 13, 2010

The market for multiple sclerosis drugs, long dominated by biologics and injectables, soon could see...

July 11, 2010

Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss...

June 14, 2010

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

June 13, 2010

An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...

June 7, 2010

Nautilus Neurosciences has launched a new treatment for migraines, the drug maker said Tuesday....

May 23, 2010

The Food and Drug Administration has granted special designation to encourage the development of a...